SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Sharp Grossmont Hospital’s East Tower is officially open for business following the completion of a three-year, $41 million renovation.
SERVICE: I.V. Society’s Product Is Rehydration
It’s not uncommon for those who enjoy San Diego’s craft beer and beach nightlife to drink too much. Visiting conventioneers, vacationers and wedding parties are particularly prone to excess (let’s call it the “carpe diem effect”).
San Diego’s 3D bioprinting firm Organovo Holdings, Inc. announced Wednesday that its subsidiary Samsara Sciences Inc. has officially launched commercial operations.
San Diego-based Apricus Biosciences Inc. announced that it has entered into agreements to raise $10 million in a registered direct offering of stocks and warrants.
San Diego-based Illumina, the world’s largest maker of DNA sequencing machines, said Sunday that it was forming a company to develop a blood test that can detect any kind of cancer at an early stage.
San Diego medical device maker ResMed announced Monday that it will buy Inova Labs of Austin, Texas.
San Diego-based Abide Therapeutics announced the appointment of Dr. Chan Beals as chief medical officer.
A two-year suspension of the medical device tax was signed into law late last month, to the delight of the industry and life science associations.
San Diego diagnostic maker Sequenom Inc. announced Thursday that it will cut 110 jobs, or about 20 percent of its workforce, and divest its North Carolina operations.
BIOTECH: HTL Life Plans to Raise $40M For Venture Fund
The La Jolla Institute for Allergy and Immunology has established a joint venture with San Diego’s HardTech Labs to fund and fuel startups focused on health and technology.
The Salk Institute announced that Reuben Shaw has been appointed director of the Salk Cancer Center.
San Diego drug developer Otonomy Inc. announced Tuesday that it has commenced a $100 million public offering of its common stock.
San Diego medical device maker NuVasive Inc. announced Tuesday that it will acquire Aliso Viejo-based Ellipse Technologies Inc. in a deal worth $410 million.
Two San Diego life science firms announced funding Tuesday: Pathway Genomics Corp. pulled in $40 million in a Series E round and GlySens Inc. raised $20 million in a Series D round.
Ionis Pharmaceuticals, formerly Isis Pharmaceuticals, announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation to IONIS-HTTRx for the treatment of patients with Huntington’s disease.